Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA031464 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA031464, RRID:AB_10599973
- Product name
- Anti-FAM83B
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human FAM83B, Gene description: family with sequence similarity 83, member B, Alternative Gene Names: C6orf143, FLJ30642, Validated applications: IHC, WB, Uniprot ID: Q5T0W9, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.6 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
Family with sequence similarity 83, member�B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild‑type epidermal growth factor receptor
FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma
Richtmann S, Wilkens D, Warth A, Lasitschka F, Winter H, Christopoulos P, Herth F, Muley T, Meister M, Schneider M
Cancers 2019;11(5):652
Cancers 2019;11(5):652
Family with sequence similarity 83, member�B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild‑type epidermal growth factor receptor
Yamaura T, Ezaki J, Okabe N, Takagi H, Ozaki Y, Inoue T, Watanabe Y, Fukuhara M, Muto S, Matsumura Y, Hasegawa T, Hoshino M, Osugi J, Shio Y, Waguri S, Tamura H, Imai J, Ito E, Yanagisawa Y, Honma R, Watanabe S, Suzuki H
Oncology Letters 2017
Oncology Letters 2017
FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma
OKABE N, EZAKI J, YAMAURA T, MUTO S, OSUGI J, TAMURA H, IMAI J, ITO E, YANAGISAWA Y, HONMA R, GOTOH M, WATANABE S, WAGURI S, SUZUKI H
International Journal of Oncology 2015;46(3):999-1006
International Journal of Oncology 2015;46(3):999-1006
No comments: Submit comment
Supportive validation
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human skin and liver tissues using Anti-FAM83B antibody. Corresponding FAM83B RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human skin and liver tissues using Anti-FAM83B antibody. Corresponding FAM83B RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol